Physician profile
Umar Bowers
NPI 1841511136
$2,820.16
in general payments reported to CMS, 2019-2025
34 companies · $540 in 2025
The $540 reported for 2025 was more than what 75% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,500 · 2020: $274 · 2021: $216 · 2022: $115 · 2023: $96.19 · 2024: $77.46 · 2025: $540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $713.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $458.41 | 2019-2025 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $409.55 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $299.14 | 2019-2025 | Breztri |
| Abbvie INC. | $214.41 | 2021-2025 | Vraylar |
| Allergan, INC. | $160.56 | 2019 | |
| Neurocrine Biosciences, INC. | $135.85 | 2019 | |
| Glaxosmithkline, LLC. | $125.66 | 2019-2025 | Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $118.50 | 2019-2025 | Verquvo |
| Ironwood Pharmaceuticals, INC | $91.81 | 2019-2021 | |
| Lilly USA, LLC | $83.53 | 2019-2025 | Jardiance, Mounjaro |
| Sanofi-Aventis U.S. LLC | $75.93 | 2019-2022 | |
| Biodelivery Sciences International, INC. | $73.34 | 2019 | |
| Aimmune Therapeutics, INC. | $65.49 | 2025 | Zenpep |
| Takeda Pharmaceuticals U.S.A., INC. | $49.87 | 2019-2020 | |
| Abbott Laboratories | $43.24 | 2025 | Freestyle Libre 3 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $37.79 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $32.77 | 2025 | Caplyta |
| Lundbeck LLC | $32.16 | 2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.35 | 2020-2025 | Xifaxan |
| Xeris Pharmaceuticals, INC. | $25.98 | 2025 | Gvoke Hypopen |
| Aroa Biosurgery Incorporated | $25.00 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $24.35 | 2025 | Rexulti |
| Biohaven Pharmaceutical Holding Company Ltd. | $21.56 | 2022 | |
| Ardelyx, INC. | $21.40 | 2025 | Ibsrela |
| Bayer Healthcare Pharmaceuticals INC. | $21.02 | 2025 | |
| Amarin Pharma, INC. | $20.82 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $18.36 | 2023 | Austedo |
| Exact Sciences Corporation | $18.14 | 2025 | Cologuard Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $17.23 | 2025 | Cobenfy |
| Esperion Therapeutics, INC. | $16.67 | 2021 | |
| Intra-Sana Laboratories | $14.91 | 2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Amgen INC. | $12.47 | 2019 | |
| Currax Pharmaceuticals LLC | $12.10 | 2022 | |
| Sunovion Pharmaceuticals INC. | $11.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Umar Bowers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.